Rosuvastatin calcium in acute coronary syndromes
@article{Aggarwal2013RosuvastatinCI, title={Rosuvastatin calcium in acute coronary syndromes}, author={R. Aggarwal and R. Showkathali}, journal={Expert Opinion on Pharmacotherapy}, year={2013}, volume={14}, pages={1215 - 1227} }
Introduction: Low-density lipoprotein cholesterol (LDL-C) reduction using 3-hydroxy-3-methyl glutaryl coenzyme A (HMGCoA) reductase inhibitors (statins) has a proven survival benefit in patients presenting with acute coronary syndromes (ACS). Patients presenting with ACS remain at significant risk of subsequent cardiovascular death and non-fatal myocardial infarction despite high compliance with current guideline indicated secondary prevention therapies. There remains, therefore, a need to… CONTINUE READING
Topics from this paper
13 Citations
Rosuvastatin protects against oxidized low-density lipoprotein-induced endothelial cell injury of atherosclerosis in vitro
- Chemistry, Medicine
- Molecular medicine reports
- 2019
- 5
- PDF
Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians
- Medicine
- Drug design, development and therapy
- 2018
- 3
- PDF
Neuroprotective Effects of Rosuvastatin in Spinal Cord Ischemia-Reperfusion Injury in Rabbits
- Medicine
- 2015
- 3
The relative bioavailability of 2 prototype fixed‐dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects
- Medicine
- Clinical pharmacology in drug development
- 2016
- 1
Synthesis and characterization of Rosuvastatin calcium impurity A; a HMG-CoA reductase inhibitor
- Chemistry
- 2017
- 5
The Effect of Exosomes Derived from Bone Marrow Stem Cells in Combination with Rosuvastatin on Functional Recovery and Neuroprotection in Rats After Ischemic Stroke
- Medicine
- Journal of Molecular Neuroscience
- 2020
- 5
Quantitative Analysis of Rosuvastatin Calcium in Bulkand Solid Pharmaceutical Dosage Forms Using Greenand Rapid Fourier-Transform Infrared SpectroscopicMethod
- Materials Science
- 2020
- PDF
Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques.
- Chemistry, Medicine
- The Analyst
- 2015
- 25
- PDF
References
SHOWING 1-10 OF 96 REFERENCES
Managing hyperlipidemia: current and future roles of HMG-CoA reductase inhibitors.
- Medicine
- American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
- 2002
- 9
- PDF
The evolving role of statins in the management of atherosclerosis.
- Medicine
- Journal of the American College of Cardiology
- 2000
- 565
- PDF
Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome.
- Medicine
- European heart journal
- 2006
- 68
- PDF
Rosuvastatin: efficacy, safety and clinical effectiveness.
- Medicine
- Expert opinion on pharmacotherapy
- 2008
- 26
Early statin initiation and outcomes in patients with acute coronary syndromes.
- Medicine
- JAMA
- 2002
- 70
- PDF
Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).
- Medicine
- The American journal of cardiology
- 2012
- 41
- Highly Influential
Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy
- Medicine
- American journal of cardiovascular drugs : drugs, devices, and other interventions
- 2001
- 61
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.
- Medicine
- Expert opinion on investigational drugs
- 2002
- 28
Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.
- Chemistry, Medicine
- Cardiovascular drug reviews
- 2002
- 174
- PDF
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
- Medicine
- The New England journal of medicine
- 2005
- 1,820
- PDF